COVID-19 Vaccination Clinic

COVID-19 Vaccinations

We are able to offer Pfizer Comirnaty COVID-19 vaccinations. To book in for a COVID-19 vaccination, please click on the book now button.

The COVID-19 Vaccination Clinics are run as a nurse facilitated clinic and do not allow time for consultations or questions with your GP. If you have any questions or concerns about receiving the vaccination, you are required to book an appointment with your usual GP first.

Important information about the PFIZER COVID-19 Vaccination

Benefits

A very large clinical trial showed that Pfizer is effective in preventing COVID-19 in people aged 12 years and older. Recent research has also shows it efficacy and safety for children 5-11. People who had two doses of Pfizer were about 95 percent less likely to get symptomatic COVID-19 than people who did not get the vaccine. It was equally effective in people over the age of 65 years, as well as people with some stable pre-existing medical conditions.  Boosters are now recommended after 5 months since your second dose.

Protection against COVID-19 starts from about 2–3 weeks after the first dose. While one dose may give some protection, it may only last for the short term. Two doses will give optimal protection. No vaccine is 100 percent effective, so it is possible that you can still get sick from COVID-19 after vaccination.

SARS-CoV-2 could potentially still infect a vaccinated person. Even if they have no symptoms or only mild symptoms, they could still pass it on to others. However, the COVID-19 vaccines currently used in Australia is effective in reducing the likelihood of a vaccinated person transmitting the virus to close contacts if the person is infected.

Special circumstances to discuss before vaccination

People with precautionary conditions for Pfizer

People with a history of any of the following conditions can receive Pfizer but advice should be sought from a GP, immunisation specialist or cardiologist about the best timing of vaccination and whether any additional precautions are recommended:

• Recent (i.e., within the past 6 months) inflammatory cardiac illness. For example myocarditis, pericarditis, endocarditis
• Acute rheumatic fever (i.e., with active myocardial inflammation) or acute rheumatic heart disease
• Acute decompensated heart failure.

People with weakened immune systems (immunocompromise)

People with immunocompromise includes those who have a medical condition that weakens their immune system. It also includes those who may be taking medications that suppress their immune system.

The Australian Government strongly recommends people with immunocompromise receive COVID-19 vaccination. Pfizer is not a live vaccine. It is safe in people with immunocompromise.

People with immunocompromise, including those living with HIV, have a higher risk of severe illness from COVID-19, including a higher risk of death.

Clinical trials for Pfizer did not include people with immunocompromise, except for a small group of people with stable HIV. We do not know if Pfizer is as effective in people with immunocompromise compared to the rest of the population. It is possible that Pfizer might not be as effective in people with immunocompromise as it is in the general population. It is important to continue other preventative measures such as physical distancing after vaccination.

Women who are pregnant or breastfeeding

Women and adolescents who are pregnant should be routinely offered Pfizer or Moderna at any stage of pregnancy. If you are trying to become pregnant you do not need to delay vaccination or avoid becoming pregnant after vaccination.

Pregnant women with COVID-19 have an increased risk of severe illness and adverse pregnancy outcomes. Real-world evidence has shown that Pfizer is safe for pregnant women and breastfeeding women.

If you are breastfeeding, you can have Pfizer. You do not need to stop breastfeeding after vaccination.

People with a history of COVID-19

If you have had COVID-19 in the past, tell your immunisation provider. COVID-19 vaccination can be deferred for up to six months after the acute illness in those who have had confirmed SARSCoV-2 infection, as evidence suggests that past infection reduces the risk of reinfection for at least 6 months. However, vaccination can start when they have recovered from the symptomatic infection. It is reasonable to be vaccinated earlier than 6 months following infection for some people. Discuss with your doctor or immunisation provider. If you have ongoing illness from COVID-19, discuss the best timing of vaccination with your treating doctor.

Pfizer and children

Pfizer has been provisionally approved for use in people aged 5 years or older, and cannot be given to younger children 4 and under.